Most clinical software is built around an encounter. Audiology software has to be built around a transaction that unfolds over years.
A hearing aid sale begins with an assessment, proceeds to a device selection and order, passes through a fitting, enters a trial period during which the patient can return the devices, and then continues into a follow-up and service relationship that commonly runs the life of the devices. Payment may be split across the patient, a third-party funder, an insurer, and in many cases a government program. The devices themselves carry serial numbers, warranties, repair histories, and a replacement cycle.
A platform that records appointments and notes handles perhaps a third of that. This article sets out what the device cycle requires, the arithmetic that makes trial-period tracking a financial control rather than an administrative one, how funding differs between Canada and the United States, and the question of manufacturer-supplied software that sits underneath the whole category.
What the device cycle requires
Five capabilities carry the commercial side of an audiology platform.
Device inventory at serial number level. Hearing aids are individually identified, warrantied, and repairable. The system needs to know which serial number went to which patient, when, under what warranty, and what has happened to it since. A practice tracking devices in a spreadsheet alongside the clinical record has a reconciliation problem that grows with volume.
Trial period tracking with a hard deadline. Where regulation grants a return right during a trial period, the practice carries an obligation that expires on a specific date per patient. The platform needs to surface that date, prompt the follow-up that resolves it, and record the outcome. This is the single most financially consequential thing the software does in this specialty.
Bundled versus unbundled service tracking. Where the device price includes years of follow-up care, the practice has sold a service obligation it must deliver without further billing. Where pricing is unbundled, each visit is billed separately. These are different revenue models and the platform has to support whichever the practice runs, including reporting on what bundled service is actually costing to deliver.
Split funding. Patient portions, third-party administrator claims, insurer contributions, and government program funding can all apply to one sale, with different documentation and different timelines. A platform built around a single payer per transaction will require workarounds.
Recall and replacement cycle management. Devices have a service life, and a practice with a mature patient base has a predictable replacement pipeline. Whether the platform surfaces that pipeline determines whether it is managed or merely awaited.
The trial period arithmetic
Trial period administration looks like a compliance task. It is a financial control, and the exposure is larger than most practices calculate.
Take a practice fitting an illustrative 20 patients a month at an average of $4,000 per binaural fitting. That is $80,000 of monthly revenue sitting inside trial periods, every dollar of it returnable until the trial closes.
Return rates in this category vary widely by practice and fitting quality. At an illustrative 10% return rate, $8,000 a month reverses. What the software influences is the portion of returns that happen because a patient struggled during the trial and nobody followed up in time. If structured trial-period follow-up converts even a quarter of those returns into retained fittings, that is $2,000 a month, $24,000 a year, from prompts rather than from clinical change.
The figures above are illustrations, not any practice's numbers. The structure is the point: revenue inside a trial period is not yet earned, and the platform's ability to surface expiring trials and prompt intervention is worth more than any other single feature in this category. Measure your own return rate before evaluating anything.
Canada and the United States: what differs
The device cycle is the same in both countries. Who pays for it is not, and funding structure is what drives the platform's billing requirements.
In Canada, funding is fragmented across provincial programs, federal programs for specific populations, workers' compensation boards, and private extended health benefits, with patient portions on top. Provincial hearing aid programs differ substantially in who qualifies, what they contribute, and what documentation they require, and a practice near a provincial border may deal with more than one. Practices also commonly handle claims for veterans, for Indigenous clients under federal programs, and for workplace hearing loss through provincial compensation boards, each with its own submission process. The platform requirement that follows is the ability to split one sale across several funders with different documentation and different payment timelines, and to track what is outstanding from each.
In the United States, traditional Medicare has historically not covered hearing aids themselves, though some Medicare Advantage plans include a hearing benefit, and coverage varies by plan and by year. Veterans Affairs is a substantial channel with its own procurement and documentation requirements. Private insurance coverage is inconsistent, third-party administrator networks manage hearing benefits for many plans with their own pricing and claim rules, and a meaningful share of fittings are private-pay. Over-the-counter hearing aids introduced in recent years have also changed the entry-level market, which affects how practices position and price the professional service component.
A Canadian practice evaluating a US-built platform should ask specifically whether provincial program billing is supported or handled by workaround, whether the system can hold multiple funders against a single sale, and where patient data is stored given PIPEDA and provincial health privacy obligations rather than HIPAA alone. A US practice should ask about third-party administrator claim handling and Medicare Advantage benefit verification, which are the equivalent friction points.
Trial period rules also differ. Return rights and trial lengths are set by regulation and vary by province and by state, and they are what the platform's trial clock has to be configured against. Confirm the requirement with the relevant regulator rather than with the vendor, then confirm the platform can be configured to it.
The manufacturer question
Audiology has a software dynamic that most specialties do not: hearing aid manufacturers supply practice management systems, sometimes at favourable pricing or bundled with purchasing relationships.
This is worth naming plainly because it is a commercial structure rather than a product judgement. Manufacturer-supplied software can be capable, well supported, and tightly integrated with the fitting software the practice already uses. It also creates a dependency that runs in the same direction as the practice's purchasing, and the questions that follow are practical ones.
What happens to the software relationship if the practice's product mix shifts away from that manufacturer. Whether the system handles competing manufacturers' devices with equal capability. What the data export contains and in what format if the practice leaves. Whether the pricing is contingent on purchasing volume, and what it becomes if that volume changes.
None of these has a universally correct answer. A practice comfortable with a primary manufacturer relationship may find the arrangement straightforward. A practice that values keeping its product selection open should understand that the software choice can quietly constrain it. The recommendation is only that the question be asked before signing rather than discovered later, and that the data export answer be obtained in writing.
Where the platforms sit
Independent audiology-specific systems are built around the device cycle: serial-numbered inventory, trial tracking, split funding, and bundled service management, with integration to the manufacturer fitting software the practice runs. For an independent practice that wants its management system separate from its purchasing relationships, this is the category to start in.
Manufacturer-supplied systems carry the advantages and the dependency described above, and are common enough in this specialty to be a mainstream option rather than an unusual one.
General allied health platforms handle scheduling, notes, and payments competently and do not handle device inventory, trial periods, or split funding without workarounds. They can suit a practice where audiology sits inside a broader clinic and device volume is low, and they are the wrong purchase for a dispensing-led practice.
Medical EMRs are the fit where audiology operates inside a physician-led ENT practice, where the requirement is medical documentation and billing rather than retail device management.
The share of revenue coming from device sales decides which of these leads the evaluation, and the country decides how demanding the funding requirement is.
Find your practice
| If this is your practice | Shortlist | The question that decides your quote |
|---|---|---|
| Dispensing-led independent practice, devices carry the revenue | Audiology-specific system, independent or manufacturer-supplied depending on your view of the dependency. | Run a full device cycle in trial: order, serial-number receipt, fitting, trial clock started, expiry prompt, outcome recorded. The trial clock is the feature to test hardest. |
| Canadian practice handling provincial, WCB, or federal program funding | Filter on funding capability before comparing features. | Whether one sale can carry several funders with separate documentation and payment tracking, whether your provincial program is supported natively, and where patient data is stored. |
| US practice with third-party administrator and Medicare Advantage volume | Audiology-specific system with claims handling for the networks you actually deal with. | Which third-party administrator networks the platform submits to, and how benefit verification is handled before the fitting rather than after. |
| Committed to one primary manufacturer, purchasing relationship established | Manufacturer system is a reasonable option, evaluated on its terms rather than its price. | What the data export contains and in what format on exit, and whether pricing is contingent on purchasing volume. Both in writing before signing. |
| Deliberately multi-manufacturer, product selection kept open | Independent audiology system. The software should not constrain the purchasing. | Whether the system handles every manufacturer's devices with equal capability, tested with the two or three brands you actually fit. |
| Audiology inside a multi-disciplinary clinic or ENT practice, low device volume | The clinic's platform decision governs, with device tracking handled separately if volume is genuinely low. | At what device volume the workaround stops being acceptable. See the multi-disciplinary software guide. |
The KlinDeck Software Hub shortlists platforms by specialty and includes a free comparison tool. Enter the written quotes you receive from two or three vendors, at your real provider count, and it works out the all-in monthly and effective monthly cost side by side. Separate US and Canadian currency handling. No published pricing, no account, nothing stored.
Open the Software Hub →The evaluation sequence
Measure the return rate first, and the share of returns that followed a trial period without structured intervention. That number sizes what better trial tracking is worth and is the strongest input to the decision.
Confirm the trial period and return requirements that apply in the practice's province or state with the relevant regulator rather than with a vendor, because those requirements define what the software must be configured to do.
Map the funding mix before shortlisting. Which programs, insurers, administrators, and boards actually pay this practice, in what proportion, and with what documentation. This is the requirement most likely to be discovered late and it is the one that separates platforms in this specialty.
Test the full device cycle in trial rather than the appointment workflow: purchase order, serial-numbered receipt into inventory, allocation to a patient, fitting documented, trial clock started, expiry surfaced, outcome recorded, and the device's warranty and repair history carried forward. A platform that handles the clinical encounter well and loses the device is the wrong purchase in this specialty.
Ask the manufacturer questions explicitly where a manufacturer system is on the shortlist: data export contents and format on exit, capability parity across competing brands, and whether pricing depends on purchasing volume.
Request one written all-in quote per shortlisted vendor at the exact provider count, with implementation, data conversion, integration with the fitting software the practice runs, and payment processing rates stated explicitly.
For a practice already running a system, amounts already paid are sunk and sit outside the comparison. Only the costs ahead count, with conversion and retraining in the one-time column spread across a twenty-four or thirty-six month horizon. Device history conversion deserves specific attention, because serial numbers, warranty dates, and repair records are the practice's service obligations rather than merely its records.
Where the all-in figures land close together, cost stops being the decider, and the decision belongs to whichever platform tracks the device cycle with the fewest gaps.
- Hearing Aid Sales Economics in an Audiology Practice
- Audiology Practice Financial Structure
- What Healthy Margins Look Like in an Audiology Practice
- How to Choose and Switch Practice Management Software
- Practice Software as a Revenue Instrument